Recombinant Shewanella halifaxensis Methionyl-tRNA formyltransferase (fmt)

What is Methionyl-tRNA formyltransferase (fmt) in Shewanella halifaxensis?

Methionyl-tRNA formyltransferase (fmt) in Shewanella halifaxensis is an enzyme that catalyzes the formylation of methionyl-tRNA (Met-tRNA) to generate formylmethionyl-tRNA (fMet-tRNA). This enzyme belongs to the transformylase family and plays a critical role in translation initiation in bacteria. S. halifaxensis is a marine bacterium that was isolated from sediment in the Atlantic Ocean near Halifax harbor in Canada, and it has gained attention for its ability to degrade explosive compounds such as hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) . The fmt enzyme in this organism, like in other bacteria, is essential for efficient protein synthesis initiation.

What is the biological significance of formylation in bacterial translation?

Formylation of methionyl-tRNA is a distinguishing feature of protein synthesis initiation in bacteria and eukaryotic organelles such as mitochondria and chloroplasts. The formyl group serves as a positive determinant for the initiation factor IF2 and as a negative determinant for the elongation factor EF-Tu . This modification ensures that the initiator tRNA is specifically used for translation initiation and not for elongation. The formylation process is crucial for ensuring translation fidelity in bacteria, as it helps distinguish initiator tRNA from elongator tRNA, thereby maintaining the accuracy of translation start site selection.

What substrates and cofactors are required for fmt enzymatic activity?

The fmt enzyme requires two primary substrates: methionyl-tRNA Met and a formyl donor. Research has demonstrated that fmt can utilize both 10-formyl-tetrahydrofolate (10-CHO-THF) and 10-formyldihydrofolate (10-CHO-DHF) as formyl group donors . The enzyme catalyzes the transfer of the formyl group from these folate derivatives to the amino group of the methionine that is attached to the initiator tRNA. The reaction produces formylmethionyl-tRNA (fMet-tRNA) and tetrahydrofolate (THF) or dihydrofolate (DHF), depending on which formyl donor was used. The ability to use 10-CHO-DHF as an alternative substrate has been verified through LC-MS/MS analysis of the DHF by-product formed during in vitro reactions .

What expression systems are optimal for producing functional recombinant S. halifaxensis fmt?

Recombinant S. halifaxensis fmt can be successfully expressed in several host systems, with Escherichia coli being the most commonly used due to its simplicity and high yield. Based on established protocols for similar proteins, expression in E. coli typically employs BL21(DE3) or Rosetta strains with pET-based expression vectors containing the fmt gene with an N-terminal or C-terminal affinity tag (His6 or GST) . Expression in E. coli should be conducted at lowered temperatures (16-20°C) after IPTG induction to enhance proper folding and solubility of the recombinant protein. Alternative expression systems include yeast, baculovirus, or mammalian cell systems, which may be beneficial when specific post-translational modifications or proper folding cannot be achieved in E. coli .

What purification strategy yields the highest purity and activity for recombinant fmt?

A multi-step purification approach typically yields the highest purity for recombinant S. halifaxensis fmt. For His-tagged constructs, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin should be employed as the initial capture step. This is followed by ion-exchange chromatography (typically using a Q-Sepharose column) to separate fmt from contaminating proteins with different charge properties. A final size-exclusion chromatography step (using Superdex 75 or 200) removes aggregates and ensures monodispersity of the purified protein. Throughout purification, it is crucial to maintain reducing conditions (typically with DTT or β-mercaptoethanol) to preserve the activity of cysteine residues that may be important for catalysis. The purified protein should achieve ≥85% purity as determined by SDS-PAGE analysis . Buffer optimization to include glycerol (10-15%) and stabilizing agents can help maintain enzymatic activity during storage.

What methods can be used to measure fmt enzymatic activity in vitro?

Several robust methods can be employed to measure the enzymatic activity of S. halifaxensis fmt in vitro:

• Radiolabeled assay: Using [14C]-formyl donor substrates (10-CHO-THF or 10-CHO-DHF) to monitor the transfer of the formyl group to Met-tRNAMet. The formylated product can be precipitated with TCA, filtered, and quantified by scintillation counting.

• HPLC-based assay: Analyzing the formation of fMet-tRNAMet by reverse-phase HPLC, which can separate the charged, uncharged, and formylated tRNA species.

• LC-MS/MS detection: Measuring the formation of DHF by-product when using 10-CHO-DHF as the formyl donor, which provides sensitive detection of enzyme activity .

• Spectrophotometric assay: Monitoring the decrease in absorbance at 340 nm associated with the oxidation of the folate cofactor during the formylation reaction.

A standard in vitro reaction typically includes purified Met-tRNAMet (100 μM), which is prepared by charging tRNAMet with methionine using methionyl-tRNA synthetase (MetRS), the formyl donor (10-CHO-THF or 10-CHO-DHF at 25 μM), and purified fmt enzyme (0.2 μg). The reaction is conducted in aminoacylation buffer and terminated after 10 minutes by adding 0.1 M HCl and 0.1 M β-mercaptoethanol .

What factors influence the catalytic efficiency of recombinant fmt?

Several factors significantly influence the catalytic efficiency of recombinant S. halifaxensis fmt:

Amino acid substitutions at conserved positions can dramatically affect enzyme activity, as demonstrated in human mitochondrial MTF where mutations in conserved residues resulted in significantly reduced formylation activity, with V_max/K_m values decreased by 107-653-fold .

How does S. halifaxensis fmt activity compare with formyltransferases from other species?

Comparative analysis of S. halifaxensis fmt with other bacterial and mitochondrial formyltransferases reveals important evolutionary and functional insights:

• Substrate specificity: Unlike mitochondrial systems where a single tRNA^Met serves dual roles in initiation and elongation , bacterial systems including S. halifaxensis typically have dedicated initiator tRNA^fMet.

• Catalytic parameters: While specific kinetic data for S. halifaxensis fmt is limited, bacterial formyltransferases generally demonstrate higher catalytic efficiency (k_cat/K_m) compared to their mitochondrial counterparts. E. coli fmt, for example, has a K_m for Met-tRNA^fMet in the low micromolar range.

• Temperature adaptation: As a marine bacterium, S. halifaxensis fmt likely exhibits cold-adapted properties with higher activity at lower temperatures compared to mesophilic bacteria, similar to adaptations observed in other enzymes from marine organisms.

• Formyl donor preference: While both bacterial and mitochondrial formyltransferases can use 10-CHO-THF and 10-CHO-DHF as formyl donors, the relative efficiency with each substrate may differ between species .

• Structural conservation: Formyltransferases share a conserved core domain for catalysis, but species-specific variations in substrate binding regions confer differences in enzyme kinetics and regulation.

How can site-directed mutagenesis reveal critical residues in S. halifaxensis fmt?

Site-directed mutagenesis provides powerful insights into structure-function relationships in S. halifaxensis fmt. Based on research with human mitochondrial MTF and bacterial formyltransferases, several strategic approaches can be employed:

• Conservation-based targeting: Align fmt sequences across multiple species to identify highly conserved residues. Studies of human MTF revealed that mutation of conserved residues significantly impacted enzyme activity. For example, the S125L mutation in human MTF reduced V_max/K_m by 107-653-fold .

• Alanine scanning mutagenesis: Systematically replace suspected catalytic or substrate-binding residues with alanine to assess their contribution to activity. This approach can identify residues involved in binding the formyl donor or positioning the methionyl-tRNA.

• Domain swapping: Create chimeric proteins containing domains from formyltransferases of different species to investigate domain-specific functions and species adaptations.

• Small-to-large substitutions: Research on human MTF mutations demonstrated that strategic positioning of small aliphatic amino acids is critical for normal function. Substituting small residues with larger ones (e.g., A89L in E. coli MTF, equivalent to S125L in human MTF) significantly reduced enzyme activity .

• Active site targeting: Focus on residues predicted to participate in catalysis or substrate recognition based on homology modeling with solved structures of related formyltransferases.

Activity assays comparing wild-type and mutant proteins should include determination of both kinetic parameters (K_m and k_cat) and thermostability measurements to distinguish between catalytic effects and structural destabilization.

What is the role of fmt in S. halifaxensis adaptation to marine environments?

S. halifaxensis was isolated from marine sediments in the Atlantic Ocean near Halifax harbor and possesses adaptations for survival in this environment . The fmt enzyme likely contributes to these adaptations in several ways:

• Cold adaptation: Marine environments, particularly in coastal Atlantic regions, often experience lower temperatures. The fmt enzyme in S. halifaxensis may have evolved kinetic properties that maintain efficient translation initiation at lower temperatures, such as reduced activation energy and higher catalytic efficiency at low temperatures.

• Halotolerance: Marine bacteria must function in environments with varying salinity. The fmt enzyme may possess structural features that maintain activity and stability under these conditions, such as increased surface negative charge or specific ion-binding sites.

• Pressure adaptation: Deep-sea conditions involve increased hydrostatic pressure. If S. halifaxensis encounters such conditions, its fmt may have structural adaptations that prevent pressure-induced denaturation.

• Metabolic efficiency: Marine environments can be nutrient-limited, requiring efficient resource utilization. The formylation process, while energy-consuming, ensures accurate translation initiation and may be particularly important under stress conditions encountered in marine habitats.

• Xenobiotic metabolism: S. halifaxensis has been noted for its ability to degrade explosive compounds like RDX . The fmt enzyme may indirectly support this metabolism by ensuring proper synthesis of the specialized enzymes involved in xenobiotic degradation.

Comparative studies examining the thermal stability, ionic strength tolerance, and kinetic parameters of S. halifaxensis fmt relative to terrestrial bacterial homologs would provide insights into these potential adaptations.

How does fmt activity relate to antibiotic resistance mechanisms?

The formylation pathway in bacteria, catalyzed by fmt, intersects with antibiotic resistance mechanisms in several important ways:

• Trimethoprim sensitivity: Research has shown that FolD-deficient mutants and fmt-overexpressing strains demonstrate increased sensitivity to trimethoprim (TMP) . This antibiotic inhibits dihydrofolate reductase (DHFR), affecting the folate cycle that produces the formyl donors required by fmt. This relationship suggests that modulating fmt activity could potentially sensitize bacteria to folate-targeting antibiotics.

• Peptide deformylase inhibitors: Following formylation by fmt, the formyl group is removed by peptide deformylase (PDF) during translation. PDF inhibitors represent a class of antibiotics, and the efficacy of these compounds depends on the prior activity of fmt to generate the formylated substrate.

• Translation inhibitors: Many antibiotics target the bacterial ribosome and translation machinery. The fidelity of translation initiation, maintained in part by the fmt-catalyzed formylation process, may influence sensitivity to certain translation inhibitors.

• Alternate formyl donors: The discovery that fmt can utilize 10-CHO-DHF as an alternative formyl donor suggests a metabolic flexibility that could influence resistance to antibiotics targeting the folate pathway.

• Stress response: Under antibiotic stress, efficient translation initiation becomes particularly critical. The formylation activity of fmt may be especially important for the synthesis of stress response proteins that contribute to antibiotic resistance.

These relationships highlight potential strategies for targeting fmt activity or its metabolic context as part of combination approaches to combat antibiotic resistance.

What strategies can resolve problems with low activity of recombinant fmt?

Researchers encountering low activity with recombinant S. halifaxensis fmt can implement several targeted strategies:

• Expression optimization:

  • Reduce induction temperature to 16-18°C to promote proper folding

  • Test multiple expression vectors with different promoters and fusion tags

  • Consider codon optimization for the expression host

  • Use specialized E. coli strains like Rosetta for rare codon expression

• Enzyme stabilization:

  • Include glycerol (10-20%) and reducing agents in purification buffers

  • Test additives like trehalose or sucrose for cryoprotection

  • Avoid freeze-thaw cycles; store small aliquots at -80°C

  • Consider rapid purification schedules to minimize time between steps

• Substrate quality:

  • Verify the integrity of tRNA substrate by gel electrophoresis

  • Confirm aminoacylation efficiency of Met-tRNAMet

  • Use freshly prepared formyl donors; 10-CHO-THF can degrade during storage

  • Consider enzymatically synthesizing 10-CHO-THF immediately before use

• Assay conditions:

  • Systematically optimize pH, temperature, ionic strength, and divalent cation concentration

  • Test different buffer systems (HEPES, Tris, phosphate) for compatibility

  • Include carrier proteins (BSA) to prevent surface adsorption

  • Consider trace contamination with inhibitors from the purification process

• Alternative approaches:

  • Express fmt as a fusion with solubility-enhancing partners like MBP or SUMO

  • Try functional complementation in an E. coli fmt knockout strain

  • Consider cell-free expression systems for difficult-to-express constructs

Methodical troubleshooting with careful documentation of each condition is essential to identify and resolve specific issues affecting recombinant fmt activity.

How can fmt-tRNA interactions be studied at the molecular level?

Multiple sophisticated techniques can provide detailed insights into fmt-tRNA interactions:

• Structural approaches:

  • X-ray crystallography of fmt-tRNA complexes provides atomic-level details of interaction interfaces

  • Cryo-electron microscopy can capture different conformational states during catalysis

  • NMR spectroscopy can map protein-RNA contacts in solution

  • Small-angle X-ray scattering (SAXS) provides low-resolution structural information on complex formation

• Biochemical methods:

  • RNA footprinting using ribonucleases or chemical probes identifies tRNA regions protected by fmt binding

  • UV crosslinking followed by mass spectrometry maps precise contact points

  • Filter binding assays quantify binding affinity and kinetics

  • Electrophoretic mobility shift assays (EMSA) visualize complex formation

• Biophysical techniques:

  • Isothermal titration calorimetry (ITC) measures thermodynamic parameters of binding

  • Surface plasmon resonance (SPR) provides real-time binding kinetics

  • Microscale thermophoresis detects binding-induced changes in molecular movement

  • Fluorescence anisotropy monitors changes in rotational diffusion upon complex formation

• Computational approaches:

  • Molecular dynamics simulations model dynamic aspects of the interaction

  • Homology modeling predicts interaction interfaces based on related structures

  • Sequence covariation analysis identifies co-evolving residues that may form contacts

• Functional assays:

  • Mutagenesis of tRNA recognition elements followed by activity assays

  • Modification interference assays identify critical chemical groups in the tRNA

  • In vivo reporter systems to monitor formylation efficiency of variant tRNAs

These approaches can be combined to build a comprehensive understanding of the molecular basis for fmt recognition of its tRNA substrate.

What considerations are important when designing fmt inhibition studies?

When designing studies to investigate inhibition of S. halifaxensis fmt, researchers should consider several critical factors:

• Inhibitor design approaches:

  • Substrate analogs targeting the formyl donor binding site

  • tRNA mimetics that compete for the tRNA binding interface

  • Transition state analogs that mimic the catalytic intermediate

  • Allosteric inhibitors targeting non-catalytic regulatory sites

  • Fragment-based screening to identify novel chemical scaffolds

• Selectivity considerations:

  • Distinguish between inhibition of fmt and related formyltransferases

  • Assess cross-reactivity with human mitochondrial MTF

  • Consider potential off-target effects on folate metabolism

  • Evaluate species-specificity among different bacterial formyltransferases

• Assay development:

  • Establish a reliable high-throughput screening assay

  • Include appropriate positive and negative controls

  • Validate hits through orthogonal assay methods

  • Determine mechanism of inhibition (competitive, noncompetitive, uncompetitive)

• In vivo validation:

  • Test effects on bacterial growth and viability

  • Evaluate synergy with existing antibiotics, particularly trimethoprim

  • Assess impact on formylation levels of nascent proteins

  • Monitor development of resistance mechanisms

• Physiological relevance:

  • Consider the essentiality of fmt in the target organism

  • Evaluate bypass mechanisms that might compensate for fmt inhibition

  • Assess conditions where fmt inhibition would be most effective

These considerations will guide the development of potential fmt inhibitors and provide a framework for evaluating their efficacy and specificity in both in vitro and in vivo settings.

How does S. halifaxensis fmt compare to formyltransferases from other extremophiles?

Comparative analysis of S. halifaxensis fmt with formyltransferases from other extremophiles reveals important adaptations to diverse environmental challenges:

• Psychrophilic adaptations: As a marine bacterium from cooler Atlantic waters, S. halifaxensis fmt likely shows structural features common to cold-adapted enzymes, including higher catalytic efficiency at low temperatures, reduced thermal stability, and greater structural flexibility compared to mesophilic homologs. These properties contrast with formyltransferases from thermophiles, which typically demonstrate enhanced rigidity and thermostability.

• Halophilic features: Marine bacteria must function in saline environments. S. halifaxensis fmt may share adaptations with formyltransferases from halophiles, such as increased surface negative charge, specific ion-binding sites, and reduced hydrophobic cores that maintain activity under varying salt concentrations.

• Pressure adaptation: Deep-sea extremophiles (barophiles) possess enzymes with structural modifications that resist pressure-induced denaturation. Depending on its habitat depth, S. halifaxensis fmt may show intermediate adaptations in this spectrum.

• Energetic efficiency: Extremophiles often face energy-limited environments. The formylation mechanism in S. halifaxensis may be optimized for energetic efficiency, potentially through altered substrate affinity or coupling with other metabolic pathways.

• Substrate recognition: Different environmental conditions can influence tRNA structure and dynamics. Formyltransferases from diverse extremophiles may show specialized adaptations in their tRNA recognition elements to accommodate environment-specific variations in tRNA stability and conformation.

Experimental approaches to investigate these comparisons include thermal stability assays, activity measurements under varying conditions of temperature, pressure, and salinity, and structural studies focusing on flexibility and solvent-exposed surfaces.

What emerging techniques could advance research on bacterial formyltransferases?

Several cutting-edge technologies are poised to transform research on bacterial formyltransferases like S. halifaxensis fmt:

• Cryo-electron microscopy (cryo-EM): Recent advances in resolution now allow visualization of enzyme-substrate complexes in near-atomic detail without crystallization. Time-resolved cryo-EM could capture formyltransferase catalytic intermediates, providing unprecedented insights into the reaction mechanism.

• Single-molecule techniques: Methods such as FRET (Förster resonance energy transfer) and magnetic tweezers can track individual fmt-tRNA interaction events, revealing conformational changes and kinetic parameters that are obscured in bulk measurements.

• Genome editing in native hosts: CRISPR-Cas9 technology enables precise genetic manipulation of S. halifaxensis and other non-model organisms, allowing direct study of fmt function in its native cellular context through targeted mutations.

• Ribosome profiling: This technique can quantify the impact of fmt alterations on translation initiation site selection and efficiency across the entire bacterial proteome, providing system-level insights into fmt function.

• Metabolomics integration: Comprehensive analysis of folate pathway metabolites in conjunction with fmt activity measurements can reveal how formylation capacity is regulated in response to environmental conditions.

• Artificial intelligence approaches: Machine learning algorithms can predict formyltransferase-specific inhibitors by analyzing structure-activity relationships and identifying novel chemical scaffolds with potential selectivity.

• In-cell NMR spectroscopy: This emerging technique allows observation of protein-RNA interactions within living cells, providing physiologically relevant information about fmt-tRNA dynamics.

These advanced techniques, particularly when used in combination, promise to address longstanding questions about the catalytic mechanism, regulation, and biological significance of bacterial formyltransferases.

What potential biotechnological applications exist for recombinant S. halifaxensis fmt?

Recombinant S. halifaxensis fmt offers several innovative biotechnological applications:

• Protein engineering tool: The formylation activity can be exploited for N-terminal modification of recombinant proteins. N-formyl-methionine can alter protein stability, solubility, and immunogenicity, providing a enzymatic alternative to chemical formylation methods. This could be particularly valuable for production of antimicrobial peptides where N-terminal formylation affects bioactivity.

• Synthetic biology applications: Orthogonal translation systems incorporating S. halifaxensis fmt could enable site-specific incorporation of N-formyl-methionine into proteins in heterologous hosts, expanding the toolkit for genetic code expansion.

• Biocatalysis platform: The enzyme's ability to transfer formyl groups could potentially be harnessed for the synthesis of formylated compounds beyond its natural tRNA substrate, especially if protein engineering is employed to alter substrate specificity.

• Marine-adapted expression systems: Understanding the cold-adapted properties of S. halifaxensis fmt could inform the development of protein expression systems optimized for low-temperature production, reducing energy costs and improving folding of difficult proteins.

• Environmental bioremediation: Given S. halifaxensis' natural ability to degrade explosive compounds like RDX , its fmt could play a role in ensuring efficient expression of xenobiotic-degrading enzymes under environmental stress conditions. Engineered systems incorporating fmt optimization might enhance bioremediation capabilities.

• Antibiotic development platform: The relationship between fmt activity and trimethoprim sensitivity suggests potential applications in screening for novel antifolate compounds or synergistic drug combinations targeting bacterial translation.

These applications leverage the unique properties of S. halifaxensis fmt while addressing current challenges in biotechnology and environmental science.